Expression of IL17A inhibits the osteogenic differentiation of MSCs [76, 77], and T cell-derived IL17A is involved in bone loss and postmenopausal osteoporosis [78, 79]. This evidence concerns the gene IL17A and postmenopausal osteoporosis.